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Abbreviations  30 
AJ, adherens junction 31 
BM-DC, bone marrow-derived dendritic cells  32 
Ctrl, unstimulated cells  33 
CV, conventional 34 
DE, desmosomes 35 
GF, germ-free 36 
HEK293, human embryonic kidney cell line 293 37 
IFN, interferon 38 
Ig, immunoglobulin  39 
IL, interleukin  40 
L, Lactobacillus 41 
L900, L. rhamnosus LOCK0900 42 
L908, L. rhamnosus LOCK0908 43 
L919, L. casei LOCK0919  44 
Lmix, Lactobacilli mixture 45 
MLN, mesenteric lymph nodes 46 
NOD2, Nucleotide-binding oligomerization domain-containing protein 2 47 
PBS, phosphate-buffered saline 48 
RBL, rat basophil leukemia cells 49 
TGF, transforming growth factor 50 
Th, T helper lymphocytes 51 
TJ, tight junction 52 
TLR, Toll-like receptor 53 
Treg, T regulatory lymphocytes 54 
TW, terminal web 55 
ZO-1, zonulin-1 56 
57 
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Abstract 58 
Increasing numbers of clinical trials and animal experiments show that probiotic bacteria are a 59 
promising tool in allergy prevention. Here we analyzed the immunomodulatory properties of 60 
three selected lactobacilli strains and the impact of their mixture on allergic sensitization to 61 
Bet v 1 using gnotobiotic mouse model. We have shown that Lactobacillus (L.) rhamnosus 62 
LOCK0900, L. rhamnosus LOCK0908, and L. casei LOCK0919 are recognized via TLR2 63 
and NOD2 receptors and stimulate bone marrow-derived dendritic cells to cytokine 64 
production in a species- and strain-dependent manner. Colonization of germ-free (GF) mice 65 
with the mixture of all tree strains (Lmix) improved intestinal barrier by strengthening the 66 
apical junctional complexes of enterocytes and by restoring the structure of microfilaments 67 
extending into the terminal web. Mice colonized with Lmix and sensitized to Bet v 1 allergen 68 
showed significantly lower level of allergen-specific IgE, IgG1, IgG2a and elevated levels of 69 
total IgA in sera and intestinal lavages as well as increased levels of TGF-β compared to 70 
sensitized GF mice. Splenocytes and mesenteric lymph node cells of Lmix-colonized mice 71 
showed significant up-regulation of TGF-β after in vitro stimulation with Bet v 1. Our results 72 
show that Lmix colonization improved gut epithelial barrier and reduced allergic sensitization 73 
to Bet v 1. Furthermore, this was accompanied by increased production of circulating and 74 
secretory IgA and regulatory cytokine TGF-β. Thus the mixture of three lactobacilli strains 75 
shows a potential to be used in prevention of increased gut permeability and onset of allergies 76 
in humans. 77 
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Introduction  83 
Humans, as all vertebrates, are essentially born germ-free (GF). The GF status changes 84 
rapidly during and after delivery and the subsequent interaction between the host and 85 
colonizing microbiota plays a crucial role in the development and function of the immune 86 
system as well as maintenance of intestinal homeostasis (1, 2). Perturbation in the colonizing 87 
microbiota leads to breakdown of equilibrium between commensal and pathogenic microbes. 88 
This dysbiosis has been linked to the increased permeability of the epithelium (3, 4) and with 89 
the development of chronic inflammatory diseases such as allergies or inflammatory bowel 90 
disease (5-7). 91 
Allergies have become a serious health burden in developed countries. In line with the 92 
general hypothesis from Strachan (8) that the rapid increase in allergic diseases in humans is 93 
dependent on microbial deprivation early in life, reduced bacterial diversity and lower counts 94 
of lactobacilli and bifidobacteria were found in gut of allergic children (9, 10). This finding 95 
has been the rationale for administration of probiotic bacteria in prevention and/or therapy of 96 
allergy (11-13).   97 
Probiotic lactobacilli and bifidobacteria are non-invasive and non-pathogenic Gram-98 
positive bacteria possessing immunomodulatory properties which are strictly strain-dependent 99 
(14). They have been documented to compete with pathogens and toxins for adherence to the 100 
intestinal epithelium, promote intestinal epithelial cell survival, enhance barrier function and 101 
directly interact with cells of the immune system such as dendritic cells (DC) (15). Through 102 
engagement of innate receptors such as TLRs, NODs or C-type lectin receptors, probiotic 103 
lactobacilli and bifidobacteria induce distinct innate responses and cytokine profiles that 104 
subsequently shape the type of T-helper cell responses (16-18). There is accumulating 105 
evidence that certain strains possess intrinsic Th1-type immunomodulatory properties (18, 19) 106 
while others are able to induce regulatory responses (17, 20, 21).  107 
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TGF-β is present at high concentrations in the intestine and has a crucial involvement 108 
in modulating the immune response (22). It has been shown to inhibit the proliferation and 109 
differentiation of both B- and T-cells (23) and altered TGF-β signaling has been linked to the 110 
development of allergic disease (24). Furthermore, TGF-β is an initial trigger for production 111 
of mucosal IgA, which has a regulating role in mucosal integrity (25). Along these lines, we 112 
have previously shown that Lactobacillus paracasei stimulated production of regulatory 113 
cytokine TGF-β from bone marrow-derived DC in a TLR2/4-deppendent manner (21).  114 
Among the inhalant allergens, pollen of the white birch (Betula verrucosa) is one of 115 
the most important sources responsible for eliciting allergic symptoms (26). In an 116 
experimental model, we have shown that oral application of L. paracasei to pregnant mothers 117 
prevented allergy development in their offspring in a mouse model of birch pollen allergy 118 
(21). Similarly, intranasal application of probiotic bacteria reduced allergic poly-sensitization 119 
in adult mice (27). Although the majority of studies use single strains the supplementation 120 
with probiotic mixtures might have greater efficacy (28).  121 
Germ-free animals represent a unique tool to study the interaction of the host with one 122 
specific probiotic strain or with defined probiotic mixture and to investigate their impact on 123 
the development of the immune system (6, 29). Using a mouse model of allergic sensitization 124 
to major birch pollen allergen Bet v 1 we have previously shown that neonatal colonization of 125 
GF mice with Bifidobacterium longum is able to prevent allergic sensitization (20), but the 126 
underlying mechanism of host-bacteria interaction in gnotobiotic models is still far from 127 
being elucidated. 128 
Recently, we have selected three lactobacilli strains L. rhamnosus LOCK0900, L. 129 
rhamnosus LOCK0908 and L. casei LOCK0919 out of twenty four strains isolated from the 130 
stool of healthy infants (30). These selected strains showed properties required for probiotic 131 
bacteria, e.g. the resistance to gastric acids and bile salts and inhibitory activity against 132 
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bacterial pathogens (30). Moreover, the mixture of these strains (Lmix) showed synergistic 133 
effects in induction of anti-allergic Th1-type cytokines and regulatory cytokine TGF-β in 134 
human whole blood cell cultures compared to the levels induced by each single strain alone 135 
(31). Our pilot study showed that supplementation of children presenting the first symptoms 136 
of allergy (atopic dermatitis) with the Lmix reduced the serum levels of IgE and IL-5 and 137 
diminished severity of the disease (Cukrowska, unpublished data).  138 
Based on these observed effects, the aims of this study were to further characterize 139 
immunomodulatory properties of individual lactobacilli strains L. rhamnosus LOCK0900, L. 140 
rhamnosus LOCK0908 and L. casei LOCK0919 as well as their mixture Lmix in vitro; and to 141 
investigate the effect of Lmix on the development of allergic sensitization to allergen Bet v 1 142 
in a gnotobiotic mouse model.  143 
 144 
Materials and Methods 145 
Bacterial strains 146 
L. rhamnosus LOCK0900 (32), L. rhamnosus LOCK0908 (33) and L. casei LOCK0919 (34) 147 
were obtained from the Pure Culture Collection of the Technical University of Lodz, Poland 148 
(LOCK). Overnight cultures in MRS broth (Oxoid, UK) were centrifuged, washed in sterile 149 
phosphate-buffered saline (PBS) and concentration was adjusted to 10
9
 CFU/ml. For in vitro 150 
experiments, single bacterial strains were inactivated with 1 % formaldehyde-PBS for 3 h at 151 
room temperature, washed twice with sterile saline (PBS), and stored at – 40 oC. 152 
 153 
Stimulation of HEK293 cells stably transfected with TLR2, NOD2 and TLR4  154 
Human embryonic kidney cell line HEK293 stably transfected with plasmid carrying human 155 
(h)TLR2/CD14 gene were kindly provided by M. Yazdanbakhsh (Leiden, Netherlands), cells 156 
transfected with hTLR4/MD2/CD14 were a gift of B. Bohle (Vienna, Austria) and cells 157 
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transfected with hNOD2 were purchased from InvivoGen (InvivoGen, USA). Cells were 158 
stimulated with formalin-inactivated single strains or their mixture in concentration 10
7
 159 
CFU/ml. TLR2 ligand Pam3CSK4 (PAM3; 1 μg/ml, InvivoGen, USA), NOD2 ligand 160 
muramyl dipeptide (MDP; 100 ng/ml, InvivoGen, USA) and TLR4 ligand ultrapure LPS-EB 161 
(LPS; 1 μg/ml, Invivogen, USA) were used as positive controls. After the 20-h incubation 162 
period, culture supernatants were harvested and concentration of human IL-8 was analyzed by 163 
ELISA (Thermo Scientific, USA) according to the manufacturer’s instructions. 164 
 165 
Preparation and activation of bone marrow-derived dendritic cells  166 
Mouse bone marrow-derived DC (BM-DC) were prepared as previously described (21). 167 
Briefly, the bone marrow precursors were isolated from femurs and tibias of conventional 168 
(CV) BALB/c mice. Cells were cultured at 4 × 10
5
/ml in bacteriological Petri dishes in 10 ml 169 
culture medium with GM-CSF (20 ng/ml; Sigma–Aldrich, USA). Fresh medium was added at 170 
days 3 and 6 and BM-DC were used on day 8 of culture. BM-DC (10
6
 cells/ml) were 171 
stimulated with 10
7
 CFU/ml of inactivated L. rhamnosus LOCK0900, L. rhamnosus 172 
LOCK0908, L. casei LOCK0919 and their equal part mixture (Lmix) for 18 h. As controls, 173 
BM-DC were incubated with Pam3CSK4 (PAM3; 1 μg/ml) or ultrapure LPS-EB (LPS, 174 
1 μg/ml). Levels of IL-10, TGF-β, and TNF-α in culture supernatants were determined by 175 
ELISA Ready-Set-Go! kits (eBioscience, USA) according to manufacturer's instructions. 176 
Levels of IL-12p70 were measured with matched antibody pairs (BD Pharmingen, USA).  177 
 178 
Animals 179 
GF inbred BALB/c mice were born and housed under sterile conditions and fed a sterile 180 
standard pellet diet (ST1, Bergman, Kocanda, Czech Republic, 59 kGy irradiated for 30 181 
minutes) and sterile water ad libitum. Animals were kept in a room with a 12 h light-dark 182 
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cycle at 22
o
C. Fecal samples were weekly evaluated for the presence of aerobic and anaerobic 183 
bacteria, molds and yeast by standard microbiological methodology. Conventional (CV) 184 
BALB/c mice (n=5) were fed with the same sterile diet as GF counterparts. Animal 185 
experiments were approved by the Committee for Protection and Use of Experimental 186 
Animals of the Institute of Microbiology. v.v.i., Academy of Sciences of the Czech Republic 187 
(approval ID: 50/2013). 188 
 189 
Experimental design 190 
Eight-week old GF mice (n = 12) were divided into two groups. Mice were colonized 191 
by intragastric tubing with 2 × 10
8
 CFU of equal parts of overnight cultures of L. rhamnosus 192 
LOCK0900, L. rhamnosus LOCK0908 and L. casei LOCK0919 in 0.2 ml sterile PBS (group 193 
1). The second group served as GF control. Three weeks after colonization, Lactobacillus-194 
colonized mice as well as GF controls where three times intraperitoneally (i.p.) immunized 195 
with 1 g of recombinant birch pollen allergen Bet v 1 (Biomay, Austria) adsorbed to 2 mg 196 
aluminum hydroxide (Alum; Serva, Germany) in 10-day intervals as described before (35). 197 
Mice were sacrificed seven days after the last immunization by cervical dislocation (Fig. 4 A). 198 
Blood was collected and sera stored at -40° C until analysis. Samples of terminal ileum were 199 
removed for immunohistochemistry, Western blot and electron microscopy analysis, and the 200 
rest of the small intestine was excised for determination of total IgA with lavages performed 201 
as previously described (36). Mesenteric lymph nodes (MLN, pooled per group) and spleen 202 
were aseptically removed and prepared for in vitro cytokine assays. Briefly, after gentle 203 
crushing, meshing through the 70 μm cell strainer (BD Falcon, USA) and the lysis of red 204 
blood cells (180 mM NH4Cl, 17 mM Na2EDTA, pH 7.3; Sigma-Aldrich, Germany), 205 
mononuclear cells were resuspended in complete RPMI-1640 medium (Sigma-Aldrich, USA) 206 
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containing 10% fetal calf serum, 2 mM glutamine, 100 U penicillin, and 100 µg/ml 207 
streptomycin.  208 
 209 
 Bacterial colonization 210 
The bacterial colonization of the mice was evaluated on the first two days and then at weekly 211 
intervals throughout the experiment. Feces were pooled per group, diluted (1:9, w/v) in sterile 212 
PBS and excessively vortexed with sterile glass beads. Volumes of 1 ml of appropriate 10-213 
fold dilution were plated into MRS agar (Oxoid, UK) and cultivated in triplicate at 37°C for 214 
48 h. On the species level, bacteria were distinguished on the basis of colonies morphology: 215 
the strain L. casei LOCK0919 formed small, white, non-mucosal colonies, whereas the strains 216 
L. rhamnosus LOCK0900 and LOCK0908 formed larger white-gray colored mucosal 217 
colonies. To distinguish between L. rhamnosus strains we isolated DNA from feces of 218 
colonized mice and performed strain specific qPCR (Supplementary Material and Methods). 219 
  220 
Immunohistochemical detection of IgA producing cells  221 
Segments of the terminal ileum were embedded in Tissue-Tek (Sakura Finetec Europe B.V., 222 
Netherlands) and frozen in liquid nitrogen. Cryosections (5 mm thick) of acetone-fixed colon 223 
were used for immunocytochemistry. Immunostaining was performed by goat anti-mouse 224 
IgA-FITC antibody (Invitrogen, USA). Samples were viewed under an Olympus BX 40 225 
microscope equipped with an Olympus DP 70 digital camera. Photographs were taken by 226 
Camedia Master 2.5 and DP-Soft (Olympus, Germany). 227 
 228 
Transmission electron microscopy 229 
The ileum tissues were cut into small pieces (1 × 1 mm) and immediately fixed in 2.5% 230 
glutaraldehyde in PBS for 90 minutes. After fixation in 1% osmium tetroxide (Sigma-Aldrich, 231 
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USA) for 1 h and washing in 0.1 M cacodylate buffer samples were successively dehydrated 232 
in 35, 70, 96 and 100% ethanol and propylene oxide (EMS, USA). Subsequently, the 233 
segments were embedded in Epon resin (EMS, USA). Ileum areas chosen according semi-thin 234 
sections were cut into 65 nm ultra-thin sections (Leica Ultracut Uct52), stained with uranyl 235 
acetate and lead citrate, and examined under electron microscope (Jem 1011, Jeol, USA). 236 
Images of the ultra-structural features of ileum structures and junctions were visualized under 237 
magnification ranged from 3000 × to 100 000 ×. Specimens were obtained from 5 mice of 238 
each group. The widths and lengths of intracellular junctions were measured using the 239 
morphometric program iTEM (Olympus, Germany) at magnification of 100 000 ×. For each 240 
specimen 10-15 measurements were performed, and results were presented in nm. 241 
 242 
Western blot analysis of ZO-1 and occludin 243 
The terminal ileum was homogenized on ice in protein extract buffer with a protease inhibitor 244 
cocktail (Pierce, USA) for 10 min and sonicated. Samples were centrifuged at 10,000× rpm 245 
for 10 min at 4°C and stored at −80°C until use. Protein concentrations were measured using 246 
the BCA Protein Assay Kit (Pierce, USA). Western blotting was performed as described 247 
previously (37). The membranes were blocked with 2% (w/v) dry milk in 0.05% PBS-Tween-248 
20 for 1 h at room temperature and incubated overnight at 4°C with antibodies against 249 
occludin (1:1000) (Invitrogen, USA), ZO-1 (1:1000) (ZYMED Laboratories Inc., USA) and 250 
β-actin (1:5000) (Abcam, USA). After incubation with the respective primary antibodies, 251 
secondary staining was conducted using horseradish peroxidase-conjugated species specific 252 
antibodies (1:1000) (ZYMED Laboratories Inc., USA) for 1 h at room temperature. The 253 
reactions were developed using the SuperSignal Weat Femto Maximum Sensitivity Substrate 254 
(ThermoScientific, USA) and the signal intensities were measured on the G:BOX (Syngene, 255 
UK) and processed with ImageJ (38). 256 
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 257 
Allergen-specific antibody responses: ELISA and basophil release assay 258 
Allergen-specific serum IgG1, IgG2a and IgA levels were determined by ELISA as 259 
previously described (39). Briefly, 96-well microtiter plates were coated with Bet v 1 (2 260 
g/ml). Serum samples were diluted 1/10000 for IgG1, 1/100 for IgG2a and 1/10 for IgA. Rat 261 
anti-mouse IgG1, IgG2a and IgA antibodies (1 g/ml, Pharmingen, USA) were applied, 262 
followed by peroxidase-conjugated mouse anti-rat IgG antibodies (1/1000; Jackson Immuno 263 
Labs, USA) for detection. Antibody levels were reported as optical density. Allergen-specific 264 
IgE levels in sera were quantified by degranulation of rat basophil leukemia (RBL-2H3) cells 265 
as previously described (40). RBL-2H3 cells were plated in 96-well tissue culture plates (4 × 266 
10
4
 cells per well) and passively sensitized by incubation with mouse sera in a final dilution 267 
of 1/30 for 2 hours. After washing, Bet v 1 (0.3 g/ml) was added for 30 min at 37oC to 268 
induce degranulation. Supernatants were incubated with 4-methylumbelliferyl-N-acetyl--D-269 
glucosaminide (Sigma-Aldrich, USA) for analysis of -hexosaminidase using a fluorescence 270 
microplate reader (ex: 360 nm/em: 465 nm) Infinite M200 (Tecan Group Ltd., Austria). 271 
Results are reported as percentage of total -hexosaminidase release from cells after 272 
disruption with 1% Triton X-100. 273 
 274 
Total IgA and IgE responses 275 
Total IgA and IgE were measured in sera and gut lavages (IgA only) by mouse IgA and IgE 276 
ELISA quantification kit (Bethyl, USA) according to manufacturer’s instruction. Sera were 277 
diluted 1/400 for IgA and 1/10 for IgE measurement, for IgA determination in gut lavages 278 
1/2500 dilution was used. Antibody levels are reported as µg/ml for sera and µg/g for gut 279 
lavages. 280 
 281 
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Cytokine production  282 
Spleen cells and pooled MLN cell suspensions were cultured in 48-well flat bottom plates at 283 
concentration 5 × 10
6
 cells in 500 µl of complete RPMI 1640 medium. Cells were cultivated 284 
with/without Bet v 1 (10 µg/well) restimulation at 37ºC under 5% CO2 for 48 h. After 285 
cultivation supernatants were collected and stored at -40°C until analysis. IL-4, IL-5, IL-10 286 
and interferon (IFN)- were determined by the Mouse cytokine/chemokine multiplex 287 
Immunoassay (Lincoplex, Millipore, USA) according to manufacturer’s instructions and 288 
analyzed with the Luminex® 200™ System (Bio-Rad Laboratories, USA) with sensitivities < 289 
0.3 pg/ml for IL-4; < 0.3 pg/ml for IL-5; < 10.3 pg/ml for IL-10; and < 0.7 pg/ml for IFN-. 290 
TGF-was measured in culture supernatants and in 1/10 diluted sera by ELISA kit (R&D 291 
Duoset Systems, USA) according to the manufacturer’s instruction with detection limit < 4 292 
pg/ml.  293 
 294 
Statistical Analyses 295 
Non-parametric Mann-Whitney test was used for comparison between two groups and for 296 
comparison between multiple groups ANOVA with Tukey’s multiple comparison test was 297 
performed with GraphPad Prism 5.02 software. Values of P < 0.05 were considered 298 
statistically different. All data are expressed as the mean ± standard error of the mean (SEM) 299 
unless stated otherwise.  300 
 301 
 302 
 303 
 304 
 305 
 306 
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Results 307 
TLR2 and NOD2 but not TLR4 are involved in the recognition of all three investigated 308 
Lactobacillus strains  309 
To specify pattern recognition receptors involved in Lactobacillus signaling pathways, single 310 
strains L. rhamnosus LOCK0900, L. rhamnosus LOCK0908, L. casei LOCK0919 and their 311 
equal part mixture (Lmix) were incubated with HEK293 cells transfected either with TLR2, 312 
TLR4 or NOD2. The IL-8 cytokine was measured as an indicator of cell stimulation via 313 
specific receptor. The level of IL-8 was significantly increased in supernatants of 314 
HEK293/TLR2 cells incubated with L. rhamnosus LOCK0900, and of HEK/NOD2 exposed 315 
to L. casei LOCK0919 and Lmix (Fig. 1A, B). There was no IL-8 stimulation in 316 
HEK293/TLR4 with any single lactobacilli strain or their mixture (Fig. 1 C).  317 
 318 
Strain-specific profile of cytokines produced by stimulated BM-DC 319 
Activation of bone marrow-derived dendritic cells (BM-DC) with single strains L. rhamnosus 320 
LOCK0900, L. rhamnosus LOCK0908, L. casei LOCK0919 and their mixture showed a trend 321 
in the increased induction of regulatory cytokine TGF-β independently of applied bacterial 322 
strain. On the other hand, the production of IL-10, IL-12p70 and TNF-α was strictly species 323 
and strain dependent and stimulation of cytokine production by Lmix corresponded to the 324 
average value of all applied bacterial strains (Fig. 2).  325 
 326 
Colonization with Lmix improves the intestinal barrier  327 
To evaluate the effect of Lmix colonization on the intestinal barrier, the ultrastructural 328 
analyses of apical part of ileal enterocytes were performed. In mice reared in conventional 329 
conditions, brush borders were regular, straight and contained microfilaments extending into 330 
the terminal web (TW) (Fig. 3 A). The apical junctional complex: tight junction (TJ), 331 
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adherens junction (AJ), and desmosome (DE) were well organized. In contrast, enterocyte 332 
brush borders of GF mice were irregularly arranged and exhibited a deficit of cytoskeletal 333 
microfilaments without elongation into the TW. As documented in Table 1, the AJ region was 334 
significantly broader and shorter in GF mice when compared to CV and Lmix-colonized 335 
mice. Interestingly, incomplete apical junctional complexes with the lack of DE were 336 
observed approximately in 30% of enterocytes of GF mice (Fig. 3 B). Lmix colonization of 337 
GF mice led to more organized arrangement of enterocyte microvilli with cytoskeletal 338 
microfilaments anchored in the TW, similarly to CV mice (Fig. 3 C). In these mice, in 339 
comparison to GF mice, DE were found in each apical junctional complex. Moreover, AJ in 340 
Lmix-colonized mice were significantly elongated and narrow as compared to GF mice and 341 
resembled those found in CV mice (Table 1). Western blot analysis of terminal ileum further 342 
confirmed the results observed in electron microscopy. The levels of ZO-1 (Fig. 3 G) were 343 
significantly increased in CV and Lmix-colonized mice compared to GF controls. 344 
Concomitantly, the levels of occludin were significantly higher in CV mice and there was a 345 
trend towards an increase in the Lmix-colonized mice (Fig. 3 H). 346 
 347 
Colonization of GF mice with the Lmix  348 
Stability of colonization with the Lmix was evaluated throughout the experiment. By plating 349 
feces on MRS agar we were able to distinguish the bacteria on the species level. As shown in 350 
Fig. 4 B, starting from the second day after colonization, concentration of L. casei reached 351 
levels between 3.3 – 5.0 x 109 CFU/g of feces, while L. rhamnosus strains were detected in 352 
concentration of 0.2 – 8.0 x 108 CFU/g. To distinguish between the two L. rhamnosus strains, 353 
we isolated the DNA from the stools and by qPCR we showed that LOCK0908 strain was 354 
more abundant compared to the LOCK0900 strain (Fig. 4 C).  355 
 356 
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Colonization by Lmix suppresses Bet v 1-specific antibody production  357 
To analyze the effect of Lmix-colonization on allergic sensitization, our recently published 358 
mouse model (20, 41) was applied and specific antibody and cytokine production were 359 
evaluated. Lmix-colonized and GF mice were immunized intraperitoneally with recombinant 360 
birch pollen allergen Bet v 1 in 10-days intervals starting three weeks after the bacterial 361 
colonization (Fig. 4 A). Colonization with Lmix significantly reduced Bet v 1-specific IgE (P 362 
< 0.03), IgG1 (P < 0.03) and IgG2a (P < 0.03) serum antibodies, compared to aged-matched 363 
Bet v 1-sensitized GF controls (Fig. 4 D-F). No differences were found in Bet v 1-specific 364 
IgA antibodies between both groups (GF: 0.187 ± 0.44 OD, Lmix: 0.167 ± 0.027 OD; p = 365 
0.857). 366 
 367 
 368 
Colonization with Lmix reduced systemic IgE and induced systemic and local IgA production 369 
Colonization of GF mice with Lmix resulted in decreased level of total IgE in serum (Fig. 5 370 
A) while total levels of IgA in serum (P < 0.013) and small intestinal lavages increased 371 
significantly (P < 0.04) in comparison with Bet v 1-senzitized GF controls (Fig. 5 B, C). In 372 
the Lmix-colonized group, the induction of activated IgA-secreting plasma cells in lamina 373 
propria of terminal ileum was confirmed by immunofluorescence staining (Fig. 5 D). On the 374 
other hand, no IgA producing cells were found in age-matched GF controls (Fig. 5 D).  375 
        376 
Lmix colonization reduced Bet v 1-specific IL-4 and IL-5 cytokine production  377 
To investigate the impact of Lmix on Th1 and Th2 cytokine production, splenocytes and 378 
pooled MLN cell from Bet v 1-sensitized mice were co-cultured with Bet v 1 in vitro. We 379 
observed significantly reduced secretion of Th2 cytokine IL-4, trend in the reduction of IL-5 380 
and slightly increased level of Th1-type cytokine IFN-γ in spleen cells supernatants from 381 
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Lmix-colonized mice compared to GF controls (Fig. 6 A-C). No IL-4 production was detected 382 
in pooled MLN cell cultures and the levels of both IL-5 (Fig. 6 D) and IFN- (GF: 5.56 pg/ml, 383 
Lmix: 1.30 pg/ml) were lower in supernatants from Lmix-colonized mice compared to GF 384 
controls.           385 
 386 
Colonization with Lmix stimulated TGF-β production 387 
To evaluate the effects of Lmix colonization on regulatory cytokine response, the level of 388 
TGF-β was determined in sera and supernatants of spleen or MLN cells co-cultured with Bet 389 
v 1 in vitro. A significant upregulation of TGF-β in sera was detected in mice colonized with 390 
Lmix compared to GF controls (P < 0.009) (Fig. 7 A). We observed significantly increased 391 
levels of TGF-β in supernatants of Bet v 1 stimulated splenocyte cultures of Lmix-colonized 392 
mice compared to GF controls (Fig. 7 B). A similar tendency was detected in supernatants of 393 
MLN cells isolated from Lmix-colonized mice (Fig. 7 C). There was no difference between 394 
Lmix-colonized and GF control groups in IL-10 production in any of cell culture supernatants 395 
(data not shown). 396 
  397 
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Discussion 398 
In the present study, we aimed to investigate the ability of the Lmix, a mixture of three 399 
lactobacilli strains L. rhamnosus LOCK0900, L. rhamnosus LOCK0908 and L. casei 400 
LOCK0919, to modulate allergic sensitization in a gnotobiotic mouse model. We showed that 401 
colonization with Lmix ameliorates Bet v 1-specific allergic responses both on humoral and 402 
cellular levels. Furthermore, Lmix colonization improved the barrier function of the gut, 403 
which was immature in GF mice.  404 
Modulation of the immune responses by single bacterial strain or by mixtures of 405 
different probiotic strains was documented in mouse models as well as in human trials (42, 406 
43). This modulation occurs either by promoting Th1-type responses (44) or by induction of 407 
regulatory cells and cytokines (20, 45). Using gnotobiotic mouse model we show that 408 
colonization with Lmix reduced serum levels of both Th2-related Bet v 1-specific IgE and 409 
IgG1 antibodies as well as Th1-related IgG2a antibody, implicating the involvement of 410 
regulatory mechanisms. This was further supported by significantly higher level of TGF-β in 411 
serum. After in vitro restimulation of splenocytes or MLN cells with Bet v 1, we observed 412 
alteration in Th2/Treg cytokine production. We detected downregulation of Th2 associated 413 
cytokines IL-4 and IL-5 and upregulation of TGF-β production in Lmix-colonized group, 414 
suggesting that Lmix-colonization induced immunoregulatory mechanisms. Previously, 415 
Feleszko et al. (45) demonstrated that oral delivery of probiotic bacteria led to suppression of 416 
allergic sensitization and airway inflammation by TGF-β-producing Treg cells, which could 417 
be found in MLN. It has also been shown that peripheral conversion of CD4+ T cells to Treg 418 
cells occurs primarily in gut-associated lymphoid tissue in the presence of TGF-β and retinoic 419 
acid (46). In line with these findings we suppose that colonization with lactobacilli mixture 420 
induces upregulation of TGF-β production in intestine and generation of Treg cells.  421 
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In correlation with increased production of TGF-β we found a significant increase in 422 
gut and serum IgA level in Lmix-colonized mice. Secretory IgA has been shown to play a 423 
crucial role in maintaining bacterial homeostasis in the gut (reviewed in (47)). These results 424 
are in accordance with previous findings that colonization of GF mice with probiotic bacteria 425 
induces activation of IgA production, and that the mixture of probiotic strains is more 426 
effective in the development of plasmablasts in the gut compared to single strains (48).   427 
The intestinal barrier is immature in GF mice (49), and Lmix significantly improves 428 
this condition. Enterocyte brush borders of GF mice were irregularly arranged and exhibited 429 
the deficit of cytoskeletal microfilaments without elongation into the terminal web. Adherens 430 
junctions in Lmix-colonized mice were significantly elongated and narrow as compared to GF 431 
mice and resembled those found in CV mice. This fortification of the intestinal barrier was 432 
further evident from the increased levels of ZO-1 and occludin proteins in Lmix-colonized 433 
and CV mice. To our knowledge this is the first report documenting the effect of lactobacilli 434 
colonization on the ultrastructure of brush border and apical junctional complexes of 435 
enterocytes in gnotobioitc mice. Along these lines, increased gut permeability was found in 436 
children with food allergy (50) and recently it was also detected in asthmatic patients (51). 437 
The homeostasis of the intestinal epithelium is maintained by a complex interplay of multiple 438 
regulatory mechanisms (52). In vitro studies presented that pro-allergic cytokine IL-4 439 
contributes to barrier impairment, in contrast to TGF-β, which enhances the barrier function 440 
and activates the expression of proteins comprising the intercellular junctions (53). In our 441 
study the improvement of gut barrier in Lmix-colonized mice was accompanied by reduced 442 
secretion of pro-allergic cytokines and significant enhancement of TGF-β.  443 
There is increasing evidence that probiotic bacteria can exhibit their activities by direct 444 
interaction with pattern recognition receptors. In this study we showed that TLR2 plays an 445 
important role in the recognition of L. rhamnosus LOCK0900 and NOD2 in the recognition of 446 
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L. casei LOCK0919. In contrast, L. rhamnosus LOCK0908 was poorly recognized by both 447 
these receptors. Interestingly, the significant feature of L. rhamnosus LOCK0908 strain is its 448 
high exopolysaccharides (EPS) production (33). Fanning et al. (54) recently showed that 449 
bifidobacterial strain producing surface EPS failed to elicit a strong immune response 450 
compared with EPS-deficient variants. It is thus tempting to speculate that the lack of TLR2, 451 
TLR4 and NOD2 activation by L. rhamnosus LOCK0908 could be caused by 452 
exopolysaccharides covering the bacterial surface and masking bioactive components, which 453 
play a role in binding to pattern recognition receptors.  454 
Previously we have shown in human blood cell cultures that application of L. 455 
rhamnosus LOCK0900, L. rhamnosus LOCK0908 and L. casei LOCK0919 strains together as 456 
a mixture has a synergistic effects in induction of anti-allergic Th1-type cytokines compared 457 
to the levels induced by each single strain alone (31). By using the mouse BM-DC we were 458 
not able to confirm these findings and we did not observe any synergistic effect in cytokine 459 
production. This discrepancy may be explained by the different way of bacterial inactivation 460 
(heating vs. formalin inactivation) (55), but also by the different donor species and cell type 461 
used. 462 
 By evaluating the bacterial colonization we were able to show that all three bacterial 463 
strains were detectable in feces till the end of the experiment. Two days after the colonization, 464 
L. casei LOCK0919 became the dominant strain in the feces of colonized mice. This finding 465 
can be related to the recent analysis of the complete genome sequence of L. casei LOCK0919 466 
which revealed the presence of factors relevant to the colonization and persistence in the 467 
human gut, including proteins with the role in the adhesion to host cell structures (34).  468 
However, further experiments are needed to test, whether the observed in vivo effects could 469 
be achieved by colonization of mice by L. casei LOCK0919 alone. Although the L. 470 
rhamnosus strains compose a minority in feces of colonized mice, we cannot exclude that 471 
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they could play an important part in the immunomodulating outcome of the mixture and that 472 
they are necessary for the successful reduction of allergic sensitization. This argument is 473 
supported by our recent finding that EPS produced by L. rhamnosus LOCK0900 strain can 474 
modulate cytokine production of BM-DC induced by another bacteria (56).  475 
To conclude, we have shown that three lactobacilli strains in Lmix - L. rhamnosus 476 
LOCK0900, L. rhamnosus LOCK0908 and L. casei LOCK0919 were able to reduce 477 
sensitization to Bet v 1. The specific serum IgE and IgG as well as production of proallergic 478 
cytokines IL-4 and IL-5 by splenocytes and MLN cells was also reduced. This suppression 479 
was accompanied by upregulation of regulatory cytokine TGF-β and by improvement of 480 
epithelial gut barrier. These results clearly point out the beneficial role of selected lactobacilli 481 
strains in the process of allergic sensitization and support their use in the early prevention of 482 
allergies. 483 
 484 
 485 
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Table 1 Effect of bacterial colonization on the width (W) and length (L) of apical intracellular 689 
junctions in the ileum of conventional (CV), germ-free (GF) and Lmix-colonized mice  690 
Group       Tight Junctions (nm)  Adherens Junctions (nm)                     691 
     W            L      W        L   692 
CV    10 ± 1   336 ± 40     30 ± 2  226 ± 50   693 
GF    10 ± 1  203 ± 50*     40 ± 10* 181 ± 40*        694 
Lmix    11 ± 3  236 ± 80     30 ± 7  234 ± 70   695 
Values are means ± SEM (nm) out of 10-15 measurements per sample, n=5 samples were 696 
taken per group. *P < 0.05, significant difference of GF group versus Lmix and CV groups  697 
 698 
 699 
 700 
 701 
 702 
 703 
 704 
 705 
 706 
 707 
 708 
 709 
 710 
 711 
 712 
 713 
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Figure legends 714 
Fig.1 Stimulation of HEK293 TLR2-, NOD2- and TLR4-transfected cells with 715 
Lactobacillus strains  716 
Human embryonic kidney cells (HEK293) stably transfected with an expression vector for 717 
human TLR2 (293-hTLR2) (A), NOD2 (pUNO-hNOD2) (B) and TLR4 (293-718 
hTLR4/MD2/CD14) (C) were cultured for 20 h with 10
7
 CFU/ml of formalin-inactivated L. 719 
rhamnosus LOCK0900 (L900), L. rhamnosus LOCK0908 (L908), L. casei LOCK0919 720 
(L919) or equal mixture of these strains (Lmix). Pam3CSK4 (PAM3; 1 μg/ml), muramyl 721 
dipeptide (MDP; 10 μg/ml) and ultra-pure lipopolysaccharide from E. coli (LPS; 1 μg/ml) 722 
were used as positive controls for TLR2, NOD2 and TLR4, respectively. Unstimulated cells 723 
(ctrl) were used as control. Stimulation was evaluated by measurement of IL-8 production; 724 
results are expressed as mean ± SEM. Pooled values of at least three experiments are shown. 725 
a – significantly different from unstimulated control, *P < 0.05, **P < 0.01, ***P < 0.001.  726 
 727 
Fig.2 Stimulation of bone marrow-derived dendritic cells with Lactobacillus strains  728 
Bone marrow-derived dendritic cells (BM-DC) were cultured with 10
7
 CFU/ml of formalin-729 
inactivated L. rhamnosus LOCK0900 (L900), L. rhamnosus LOCK0908 (L908), L. casei 730 
LOCK0919 (L919) strains and equal mixture of these strains (Lmix) for 18 h. As positive 731 
controls, Pam3CSK4 (PAM3; 1 μg/ml) or ultra-pure lipopolysaccharide from E. coli (LPS; 732 
1 μg/ml) were applied. Unstimulated cells (ctrl) served as negative controls. Levels of IL-10, 733 
TGF-β, IL-12p70 and TNF-α in culture supernatants were determined by ELISA and 734 
expressed as mean values ± SEM. Pooled values of three experiments are shown. a – 735 
significantly different from unstimulated control, *P < 0.05, **P < 0.01, ***P < 0.001. 736 
 737 
 738 
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Fig.3 The effect of Lmix-colonization on architecture of the apical junctional complex of 739 
enterocytes and production of ZO-1 and occludin 740 
Electron microscopy micrograph of the apical surface of ileal enterocytes in conventional 741 
(CV), germ-free (GF) and Lmix-colonized mice (Lmix). The epithelial surface is covered by 742 
microvilli. Microfilaments extend from the microvilli into apical cytoplasm and filamentous 743 
terminal web (TW), which was lacking in the GF animals and restored in Lmix-colonized 744 
mice (A-C). The epithelial cell junctional complex contains the tight junctions (TJ), adherens 745 
junctions (AJ) and desmosomes (DE). DE were absent in 30 % of junctional complexes in 746 
GF mice (D-F). Representative micrographs out of 10-15 measurements per sample, n=5 747 
samples per group. Western blot analysis of ZO-1 (G) and occludin (H) in ileum. 748 
Representative mouse per group is shown (3-4 mice per group were analyzed,). 749 
Quantification of the signals was done using the ImageJ. Data are expressed as mean ± SEM 750 
of 3-4 mice per group. *P < 0.05, **P < 0.01.  751 
 752 
Fig.4 Sensitization of GF and Lmix-colonized mice with major birch pollen allergen Bet v 753 
1 754 
(A) Experimental design: eight-week old germ-free (GF) mice (n = 12) were divided into two 755 
groups. The first group (Lmix) received equal parts (2 × 10
8
 CFU/ ml) of L. rhamnosus 756 
LOCK0900, L. rhamnosus LOCK0908 and L. casei LOCK0919 by intragastric tubing. The 757 
second group was kept GF. Mice were sensitized three times intraperitoneally (i.p.) with 758 
recombinant Bet v 1 (1µg in alum) on days 77, 87 and 97. One week after the last 759 
immunization (day 104) tissue samples were collected for further analyses. Bacterial 760 
colonization of the Lmix-colonized mice was evaluated on the first two days and then at 761 
weekly intervals throughout the experiment. On the species level bacteria were distinguished 762 
based on different colony morphology by cultivation of appropriate serial dilution of feces 763 
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(B). L. casei LOCK 919 (full circles, solid line), L. rhamnosus LOCK 900 and LOCK 908 764 
(open squares, dotted line). L. rhamnosus strain-specific discrimination was performed by 765 
qPCR on DNA isolated from feces at indicated time points (C). L. rhamnosus LOCK 900 766 
(grey bars), L. rhamnosus LOCK 908 (black bars). Data are shown as percentage of each 767 
strain from all detected L. rhamnosus bacteria at given day after colonization. Bet v 1-768 
specific antibodies were measured in sera of GF (white bars) and Lmix-colonized mice 769 
(black bars).  IgE was measured by Bet v 1-mediated β-hexosaminidase release from rat 770 
basophil leukemia cells (D). Levels of IgG1 (E) and IgG2a (F) were evaluated by ELISA and 771 
expressed as optical density (OD) units. Data are shown as mean values ± SEM. One 772 
representative out of two experiments is shown, n = 6/ group. *P < 0.05, **P < 0.01.  773 
 774 
 775 
Fig.5 Local and systemic humoral responses in sensitized GF and Lmix-colonized mice 776 
Levels of total IgE (A) and total IgA (B) in sera and total IgA (C) in gut lavage were 777 
measured by ELISA. Germ-free mice (GF, white bars) and Lmix-colonized mice (Lmix, 778 
black bars). Data are shown as mean values ± SEM.  One representative out of two 779 
experiments is shown, n = 6/ group. *P < 0.05, **P < 0.01. The IgA-positive plasmocytes in 780 
lamina propria of terminal ileum were visualized by FITC labeled anti-IgA antibody (D). 781 
 782 
Fig.6 The effect of Lmix colonization on cytokine production in vitro 783 
Spleen and pooled mesenteric lymph node (MLN) cells of Bet v 1-sensitized GF (white bars) 784 
and Lmix-colonized mice (black bars) were re-stimulated with Bet v 1 (10 µg/well) for 48 785 
hours. The levels of IL-4 (A), IL-5 (B) and IFN-γ (C) in spleen cell cultures and IL-5 (D) in 786 
pooled MLN were determined by ELISA. Results are expressed after subtraction of cytokine 787 
  
 33 
levels measured in supernatants of non-stimulated cell cultures. One representative out of 788 
two experiments is shown, n = 6/ group. *P < 0.05. 789 
 790 
Fig.7 The effect of Lmix colonization on systemic and local TGF-β production 791 
The level of TGF-β in Bet v 1-sensitized GF (white bars) and Lmix-colonized mice (black 792 
bars) in sera (A) and in supernatants from Bet v 1-re-stimulated spleen cell (B) or pooled 793 
mesenteric lymph node (MLN) cell (C) cultures was determined by ELISA. Results are 794 
expressed after subtraction of cytokines measured in supernatants of non-stimulated cell 795 
cultures. One representative out of two experiments is shown, n = 6/ group. **P < 0.01, *P < 796 
0.05. 797 
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 799 







